Norovirus vaccine against experimental human Norwalk Virus illness. - sprookjes - yvandenbroek - TriplyDB

Norovirus vaccine against experimental human Norwalk Virus illness.

Norovirus vaccine against experimental human Norwalk Virus illness.

http://www.wikidata.org/entity/Q37144052

about

Norovirus immunity and the great escape Immunogenetic mechanisms driving norovirus GII.4 antigenic variation The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control Self-assembling protein nanoparticles in the design of vaccines A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review Tropical and travel-associated norovirus: current concepts Norovirus Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae Advances in norovirus biology Experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses Norovirus gastroenteritis in immunocompromised patients Norovirus immunology: Of mice and mechanisms Seroepidemiology of norovirus-associated travelers' diarrhea Prevalence and genetic diversity of norovirus among patients with acute diarrhea in Guatemala Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine Norovirus Regulation by Host and Microbe.Virus like particle-based vaccines against emerging infectious disease viruses.Antiviral targets of human noroviruses Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study.Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.Vaccine against norovirus.B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.The state of norovirus vaccines.Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.The dynamics of GII.4 Norovirus in Ho Chi Minh City, Vietnam Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Subviral particle as vaccine and vaccine platform.Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.Branched-linear and agglomerate protein polymers as vaccine platforms.Norovirus in healthcare settings.TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines Epidemiology of human noroviruses and updates on vaccine development Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children Replication of human noroviruses in stem cell-derived human enteroids.Epidemiology and evolution of rotaviruses and noroviruses from an archival WHO Global Study in Children (1976-79) with implications for vaccine design.A polymer/oil based nanovaccine as a single-dose immunization approach.

P2860

Q21090486-E52D3B28-D89B-428C-8585-7D825DA78FF3 Q24810360-EF500577-9613-4FC9-8A01-9715FB8446BA Q26749653-F79296D5-CC3A-46E1-9B6A-6800A83E3736 Q26767097-9AA381EB-F48C-4602-A36F-2511FE461709 Q26783083-511E2268-930E-4E3D-A15E-62A0BA303CE0 Q26799737-433B4ED1-ADD9-449C-A81E-3D30D24A2CCF Q26864280-5BEC731B-D735-43EC-BD04-8A758E3A31CB Q27004488-23B0871C-A6F5-4CD4-B0F4-729841433A10 Q27016152-50118C15-CA67-405D-9A52-66F51F4535CB Q27302049-70B55923-4E19-4EDE-B97F-61D3E9D602B0 Q27694610-C4C45B21-2C68-42DC-9B8D-3F9B1CF5F888 Q28083087-48D4480C-87FF-4139-9A97-76AFEAA4AE28 Q28395024-0D4CF0F6-BB30-4863-8AF0-74497D598126 Q28395062-0387802B-2C9E-4D58-A07D-7D01762D1AA2 Q28728786-0E430E62-BF29-4DC2-82EF-86C1D534AC92 Q30240631-C42C68FA-3A76-400A-9D82-1467C3DF96D1 Q30249025-879B2BB6-276E-44B6-85F3-FE5E638F1749 Q30249527-459A56DB-8EE7-4DC4-A336-0108CE62ECD8 Q30277091-49248061-52F7-4A0F-A68C-C132AB9EBB85 Q30401642-1CFF0F51-1E22-46C9-BB16-AE4E3DF6B84F Q30425145-609D81DB-57B4-4E6B-8CDC-DA2601232AC7 Q33578075-2C3CB939-732B-4D64-B812-08D0F9AA6953 Q33654573-F66E9182-87F2-4600-BC18-652FEF2D6C7A Q33678125-66951DED-596D-4BB8-8176-E105F89E3916 Q33703664-68AD9505-BF5C-4518-A004-407659089A75 Q33719999-4A1106A1-2E9B-4A61-AAB6-19055205D597 Q33743992-334871F4-281A-4073-BD8B-5F6BBD903EF9 Q33812653-D3525EEB-E3CC-4FF4-B8FB-5541BB5E9216 Q34033764-2D4E6017-AB1F-4197-892D-D5DB2D0DB484 Q34059136-2EA26628-93F8-427F-95B6-B6C4EF3155FE Q34059360-A1B1CCD6-64C2-4C03-8AD4-F2802AD0F6B8 Q34059409-169FFB2B-02A5-4BCD-AB28-F085F1147C71 Q34064413-67F1EC18-D231-4FC2-80D9-56CE0D45F400 Q34134280-B3F041A8-A621-41D3-9656-D3C09FA563B6 Q34290717-AF356527-9F6F-4782-9D6F-313FA5E1C07F Q34385139-31C40D0F-8DBE-4BA4-9408-50AB953A0D20 Q34452871-F48D936E-7397-438E-AF75-F3E10C764EF1 Q34538562-E31FE24D-6FFF-4070-BEEB-A99C8EA1B482 Q34639704-DDA9B1F5-0285-471E-BDBC-0E3505B88FFB Q34685874-D97A5C82-25A7-48A8-9542-8DED12BCE079

P2860

Norovirus vaccine against experimental human Norwalk Virus illness.

http://www.wikidata.org/entity/Q37144052

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Norovirus vaccine against experimental human Norwalk Virus illness.

@en

Norovirus vaccine against experimental human Norwalk Virus illness.

@nl

type

label

Norovirus vaccine against experimental human Norwalk Virus illness.

@en

Norovirus vaccine against experimental human Norwalk Virus illness.

@nl

prefLabel

Norovirus vaccine against experimental human Norwalk Virus illness.

@en

Norovirus vaccine against experimental human Norwalk Virus illness.

@nl

P1433

Q37144052-00B72767-ED8F-477E-866D-F5011D1D4623

P1476

Q37144052-DA7364A4-9C41-40E7-B596-62821019E85A

P2093

Q37144052-101735CB-B6AF-4E5C-9561-71DFB48FBE5D

Q37144052-234E8F17-A667-4977-B97C-3CE5F598192A

Q37144052-2721AA10-C0F7-49F1-A6BD-512C37C02A77

Q37144052-357D35BD-B208-484F-9BA6-B8A71B9832BC

Q37144052-4C449FA3-BF11-4AA5-903E-EB35CA59CE2E

Q37144052-6E51044A-AD2C-47DB-8CD6-123ED2B1CE14

Q37144052-74E7029E-D2B7-4349-8E26-574120BCB8BC

Q37144052-F3158BDC-DC81-47D1-B391-3655CA095656

P2860

Q37144052-0F9A4C94-8F65-4199-AA5B-7BD7F828B0C6

Q37144052-1963FBD7-90C2-4973-A2D5-55576D3814D2

Q37144052-2B38811C-C447-448C-854D-330BE7A20638

Q37144052-2B8570F1-5019-44C1-8685-8ED3A03632B8

Q37144052-2D96CF0F-A464-46ED-AD55-D80E60726C19

Q37144052-363EEA09-3775-48FB-9991-97950A400EE1

Q37144052-427C4CBB-1E46-4A97-897E-5295A3FA3BBA

Q37144052-43DCBD3A-C2E4-4D0C-989A-0BB0741F42F9

Q37144052-4502F301-2F02-4610-B7A2-4ACEFB577E53

Q37144052-46248D7A-B926-4FE7-A6F4-7E01AC8152D8

P304

Q37144052-9FC0E0C0-D882-4DE3-A084-EA974A398914

P31

Q37144052-4886632B-2E60-4DAD-9F17-A44162255CE2

P356

Q37144052-E5A1E161-DE39-4B28-8B1C-91F23242C17C

P407

Q37144052-776C5DF8-5AA8-4FDB-9685-1B05865028B6

P433

Q37144052-54C8A0DB-0754-4D1D-9BD5-7EF3D14A3C8C

P478

Q37144052-25D2B1EE-7ACE-4C7B-8F16-0A6146C19994

P50

Q37144052-350C322C-7493-4CFF-9A39-8C4137B8EF49

Q37144052-5D81BB76-21AF-4F32-82BC-A5E8F3A35B67

Q37144052-8A4D5639-559C-4398-9EFA-38287AD4C8CA

P577

Q37144052-13B16B8E-9459-4391-AE52-7354500E92FB

P698

Q37144052-23315774-486F-4F4D-9F7F-66C48E8E158E

P921

Q37144052-1F40D819-2EA6-4EB2-86E5-391E1FCD07B7

Q37144052-4958E0BE-750E-4458-AB90-7F73AF5F3AC8

P932

Q37144052-10E9C9B1-CB01-4C99-BA56-8009973523BE

P356

P1433

The New England Journal of Medicine

P1476

Norovirus vaccine against experimental human Norwalk Virus illness.

@en

P2093

Antone R Opekun

http://www.w3.org/2001/XMLSchema#string

Charles Richardson

http://www.w3.org/2001/XMLSchema#string

Clayton D Harro

http://www.w3.org/2001/XMLSchema#string

David I Bernstein

http://www.w3.org/2001/XMLSchema#string

Jennifer Ferreira

http://www.w3.org/2001/XMLSchema#string

Mohamed S Al-Ibrahim

http://www.w3.org/2001/XMLSchema#string

Paul M Mendelman

http://www.w3.org/2001/XMLSchema#string

Wilbur H Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid evolution of pandemic noroviruses of the GII.4 lineage

Norwalk virus shedding after experimental human infection

Foodborne illness acquired in the United States--major pathogens

Comprehensive analysis of a norovirus-associated gastroenteritis outbreak, from the environment to the consumer

Human susceptibility and resistance to Norwalk virus infection

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Norovirus gastroenteritis, carbohydrate receptors, and animal models.

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice

Serological correlate of protection against norovirus-induced gastroenteritis

P304

2178-2187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1101245

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

365

http://www.w3.org/2001/XMLSchema#string

P50

David Y. Graham

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22150036

http://www.w3.org/2001/XMLSchema#string

P921

P932

3761795

http://www.w3.org/2001/XMLSchema#string